Treatment of metastatic breast cancer - Economic and ethical considerations

被引：1
|
作者：
Richter, G [1 ]
机构：
[1] UNIV VIRGINIA,CTR BIOMED ETH,CHARLOTTESVILLE,VA
来源：
CANCER INVESTIGATION | 1997年 / 15卷 / 04期
关键词：
D O I：
10.3109/07357909709039737
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：335 / 341
页数：7
相关论文
共 50 条
  • [41] Pertuzumab for the treatment of metastatic breast cancer
    Langdon, Simon P.
    Cameron, David A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (08) : 907 - 918
  • [42] Bisphosphonates in the treatment of metastatic breast cancer
    Body, JJ
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2001, 6 (04) : 477 - 485
  • [43] Gemcitabine for the treatment of metastatic breast cancer
    Jones, J.
    Takeda, A.
    Tan, S. C.
    Cooper, K.
    Loveman, E.
    Clegg, A.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 1 - 7
  • [44] Strategies in the treatment of metastatic breast cancer
    Borquez, D
    Seeber, S
    ONKOLOGIE, 1999, 22 : 16 - 17
  • [45] Herceptin in the treatment of metastatic breast cancer
    Konecny, G
    Untch, M
    Pegram, M
    GYNAKOLOGE, 1999, 32 (08): : 624 - 631
  • [46] Economic evaluation of antiaromatase agents in the second-line treatment of metastatic breast cancer
    Shailendra Verma
    Angela Rocchi
    Supportive Care in Cancer, 2003, 11 : 728 - 734
  • [47] Economic evaluation of antiaromatase agents in the second-line treatment of metastatic breast cancer
    Verma, S
    Rocchi, A
    SUPPORTIVE CARE IN CANCER, 2003, 11 (11) : 728 - 734
  • [48] ECONOMIC IMPACT OF THE INCLUSION OF PERTUZUMAB FOR THE TREATMENT OF METASTATIC BREAST CANCER HER2+
    Nazco, G.
    Gutierrez, F.
    Bullejos, M.
    Vina, M.
    Gonzalez, I
    Valcarcel, C.
    VALUE IN HEALTH, 2014, 17 (07) : A638 - A638
  • [49] Economic assessment of Clodronate in the preventive treatment of bone resorption in patients with metastatic breast cancer
    Guignard, E
    Dardenne, J
    Pelc, A
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : PP30 - PP30
  • [50] Level of Evidence and Ethical Considerations for Locoregional Treatments in Metastatic Cervical Cancer Reply
    Wang, Yufeng
    VanderWalde, Noam
    Ballo, Matthew T.
    JAMA ONCOLOGY, 2019, 5 (04) : 575 - 576
12345